Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.4.2 to the page. Deleted the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check8 days agoChange DetectedA government funding notice banner was added to the page. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check15 days agoChange DetectedThe updates are minor copy edits and a version bump (Show glossary added; capitalization changes for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; Revision updated from v3.3.4 to v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a Locations section with Texas as a study site, expanding where the trial is recruiting. The footer revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check80 days agoChange DetectedMinor textual updates to the Publications section clarify that PubMed entries are automatically filled and may not all be related to the study. The page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.